Transfemoral transcatheter aortic valve implantation in patients with end-stage renal disease and kidney transplant recipients

Transcatheter aortic valve implantation (TAVI) has evolved to a treatment of choice in high-risk patients and is therefore ideal for patients with advanced chronic kidney disease, as patients with end-stage renal disease and kidney transplant recipients. Especially, outcome of this special patient g...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Rashid, Fadi, Bienholz, Anja, Hildebrandt, Heike Annelie, Patsalis, Polycarpos-Christos, Totzeck, Matthias, Kribben, Andreas, Wendt, Daniel, Jakob, Heinz, Lind, Alexander, Jánosi, Rolf Alexander, Rassaf, Tienush, Kahlert, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663698/
https://www.ncbi.nlm.nih.gov/pubmed/29089579
http://dx.doi.org/10.1038/s41598-017-14486-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663698/
https://www.ncbi.nlm.nih.gov/pubmed/29089579
http://dx.doi.org/10.1038/s41598-017-14486-7

Ejemplares similares